| Literature DB >> 32599976 |
Keeho Park1,2, Youngae Kim1, Hyung Kook Yang1, Hye Sook Min1.
Abstract
PURPOSE: It is important to understand the differences between men and women when it comes to attitudes and risk perception toward disease. This study aimed to explore the fear of cancer from the standpoint of themselves and the opposite sex by cancer type.Entities:
Keywords: Cancer; Complication; Difference; Fear; Sex
Mesh:
Year: 2020 PMID: 32599976 PMCID: PMC7577813 DOI: 10.4143/crt.2020.285
Source DB: PubMed Journal: Cancer Res Treat ISSN: 1598-2998 Impact factor: 4.679
General characteristic of the study population
| Characteristic | Total (n=1,000) | Men (n=501, 50.1%) | Women (n=499, 49.9%) | p-value[ |
|---|---|---|---|---|
| 20-29 | 167 (16.7) | 89 (17.8) | 78 (15.6) | 0.840 |
| 30-39 | 188 (18.8) | 95 (19.0) | 93 (18.6) | |
| 40-49 | 216 (21.6) | 110 (22.0) | 106 (21.2) | |
| 50-59 | 209 (20.9) | 105 (21.0) | 104 (20.8) | |
| 60-69 | 206 (20.6) | 95 (19.0) | 111 (22.2) | |
| ≥ 70 | 14 (1.4) | 7 (1.4) | 7 (1.4) | |
| Married | 704 (70.4) | 333 (66.5) | 371 (74.3) | < 0.001 |
| Widowed | 32 (3.2) | 8 (1.6) | 24 (4.8) | |
| Divorced/Separated | 34 (3.4) | 18 (3.6) | 16 (3.2) | |
| Single | 230 (23.0) | 142 (28.3) | 88 (17.6) | |
| Middle school or lower | 88 (8.8) | 30 (6.0) | 58 (11.6) | 0.002 |
| High school | 422 (42.2) | 206 (41.1) | 216 (43.3) | |
| College or higher | 490 (49.0) | 265 (52.9) | 225 (45.1) | |
| ≤ 0.99 | 119 (11.9) | 36 (7.2) | 83 (16.6) | < 0.001 |
| 1-1.99 | 147 (14.7) | 36 (7.2) | 111 (22.2) | |
| 2-2.99 | 229 (22.9) | 126 (25.1) | 103 (20.6) | |
| 3-3.99 | 241 (24.1) | 148 (29.5) | 93 (18.6) | |
| 4-4.99 | 150 (15.0) | 91 (18.2) | 59 (11.8) | |
| ≥ 5 | 114 (11.4) | 64 (12.8) | 50 (10.0) | |
| Employed | 751 (75.1) | 455 (90.8) | 296 (59.3) | < 0.001 |
| Housewife | 180 (18.0) | 0 | 180 (36.1) | |
| Student | 39 (3.9) | 26 (5.2) | 13 (2.6) | |
| Not employed | 30 (3.0) | 20 (4.0) | 10 (2.0) |
Values are presented as number (%).
Chi-square test was used.
Awareness of the least fearful cancer and the most fearful cancer among men and women
| Cancer type | Men | Rank difference | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5-Year relative survival rate (rank) (A) | Least fearful cancer (rank) | Most fearful cancer (rank) | 5-Year relative survival rate (rank) (F) | Least fearful cancer (rank) | Most fearful cancer (rank) | |||||||||||
| Me (B) | Assuming I am a woman (C) | Me (D) | Assuming I am a woman (E) | Me (G) | Assuming I am a woman (H) | Me (I) | Assuming I am a woman (J) | B-A | G-F | C-G | E-I | H-B | J-D | |||
| Stomach | 7 | 2 | 2 | 5 | 1 | 6 | 2 | 3 | 1 | 6 | –5 | –4 | 0 | 0 | 1 | 1 |
| Colon | 6 | 5 | 12 | 4 | 9 | 7 | 9 | 7 | 6 | 4 | –1 | 2 | 3 | 3 | 2 | 0 |
| Lung | 11 | 9 | 10 | 1 | 7 | 11 | 10 | 9 | 3 | 1 | –2 | –1 | 0 | 4 | 0 | 0 |
| Liver | 9 | 8 | 11 | 3 | 10 | 12 | 13 | 8 | 10 | 2 | –1 | 1 | –2 | 0 | 0 | –1 |
| Thyroid | 1 | 1 | 1 | 10 | 12 | 1 | 1 | 2 | 13 | 11 | 0 | 0 | 0 | –1 | 1 | 1 |
| Prostate | 2 | 3 | - | 6 | - | - | - | 1 | - | 5 | 1 | - | - | - | –2 | –1 |
| Bladder | 5 | 4 | 6 | 11 | 14 | 8 | 5 | 4 | 14 | 10 | –1 | –3 | 1 | 0 | 0 | –1 |
| Renal | 4 | 7 | 7 | 9 | 13 | 4 | 6 | 6 | 12 | 9 | 3 | 2 | 1 | 1 | –1 | 0 |
| Pancreatic | 12 | 11 | 14 | 2 | 6 | 14 | 14 | 11 | 2 | 3 | –1 | 0 | 0 | 4 | 0 | 1 |
| Bile duct and gallbladder (tie) | 10 | 6 | 8 (tie) | 8 | 11 | 13 | 8 | 5 | 11 | 8 | –4 | –5 | 0 | 0 | –1 | 0 |
| Leukemia | 8 | 10 | 13 | 7 | 8 | 10 | 12 | 10 | 8 | 7 | 2 | 2 | 1 | 0 | 0 | 0 |
| Breast | 3 | 12 | 3 | 12 | 2 | 2 | 3 | 12 | 4 | 12 | 9 | 1 | 0 | –2 | 0 | 0 |
| Cervical | - | - | 4 | - | 5 | 5 | 4 | - | 7 | - | - | –1 | 0 | –2 | - | - |
| Uterine (endometrial) | - | - | 5 | - | 3 | 3 | 7 | - | 5 | - | - | 4 | –2 | –2 | - | - |
| Ovarian | - | - | 8 (tie) | - | 4 | 9 | 11 | - | 9 | - | - | 2 | –3 | –5 | - | - |
Comparison of cancer fear between men and women
| Cancer type | Men | Women | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Least fearful cancer | Most fearful cancer | Least fearful cancer | Most fearful cancer | |||||||||
| Men’s response | Women’s response | p-value[ | Men’s response | Women’s response | p-value | Men’s response | Women’s response | p-value | Men’s response | Women’s response | p-value | |
| Stomach | 1.24±1.23 | 0.92±1.16 | < 0.001 | 0.45±0.97 | 0.37±0.83 | 0.160 | 0.97±1.16 | 0.94±1.14 | 0.743 | 0.83±1.15 | 0.93±1.15 | 0.185 |
| Colon | 0.46±0.93 | 0.36±0.83 | 0.084 | 0.82±1.08 | 0.80±1.07 | 0.760 | 0.24±0.69 | 0.13±0.53 | 0.005 | 0.53±0.97 | 0.42±0.89 | 0.045 |
| Lung | 0.21±0.67 | 0.26±0.71 | 0.245 | 1.43±1.27 | 1.41±1.26 | 0.877 | 0.16±0.59 | 0.14±0.54 | 0.724 | 0.82±1.14 | 0.54±0.99 | < 0.001 |
| Liver | 0.26±0.70 | 0.29±0.71 | 0.573 | 1.02±1.13 | 0.98±1.10 | 0.609 | 0.10±0.43 | 0.13±0.55 | 0.228 | 0.41±0.84 | 0.35±0.77 | 0.279 |
| Thyroid | 1.32±1.25 | 1.09±1.24 | 0.004 | 0.07±0.39 | 0.05±0.38 | 0.367 | 1.98±1.17 | 1.45±1.31 | < 0.001 | 0.06±0.34 | 0.16±0.61 | 0.002 |
| Prostate | 1.09±1.16 | 1.26±1.27 | 0.028 | 0.37±0.86 | 0.38±0.91 | 0.782 | - | - | - | - | - | - |
| Bladder | 0.46±0.87 | 0.51±0.94 | 0.405 | 0.05±0.30 | 0.07±0.42 | 0.336 | 0.34±0.76 | 0.36±0.78 | 0.704 | 0.05±0.34 | 0.08±0.39 | 0.228 |
| Renal | 0.28±0.71 | 0.40±0.84 | 0.014 | 0.13±0.51 | 0.17±0.58 | 0.216 | 0.32±0.79 | 0.27±0.66 | 0.200 | 0.08±0.34 | 0.14±0.53 | 0.017 |
| Pancreatic | 0.10±0.43 | 0.18±0.61 | 0.011 | 1.04±1.17 | 0.94±1.18 | 0.170 | 0.08±0.37 | 0.06±0.33 | 0.366 | 0.83±1.17 | 0.57±0.94 | < 0.001 |
| Bile duct and gallbladder | 0.35±0.78 | 0.46±0.84 | 0.025 | 0.17±0.56 | 0.22±0.66 | 0.193 | 0.25±0.65 | 0.26±0.71 | 0.799 | 0.11±0.44 | 0.20±0.66 | 0.010 |
| Leukemia | 0.17±0.62 | 0.19±0.63 | 0.710 | 0.29±0.77 | 0.34±0.85 | 0.318 | 0.13±0.53 | 0.13±0.55 | 0.965 | 0.44±0.92 | 0.46±0.96 | 0.760 |
| Breast | 0.03±0.24 | 0.05±0.32 | 0.214 | 0.20±0.22 | 0.44±0.34 | 0.186 | 0.57±0.94 | 0.85±1.13 | < 0.001 | 0.66±1.07 | 0.82±1.20 | 0.024 |
| Cervical | - | - | - | - | - | - | 0.52±0.93 | 0.81±1.12 | < 0.001 | 0.49±0.97 | 0.57±1.03 | 0.207 |
| Uterine (endometrial) | - | - | - | - | - | - | 0.29±0.71 | 0.40±0.82 | 0.020 | 0.59±1.01 | 0.64±1.04 | 0.503 |
| Ovarian | - | - | - | - | - | - | 0.13±0.49 | 0.26±0.69 | 0.001 | 0.44±0.91 | 0.63±1.05 | 0.002 |
Values are presented as mean±standard deviation.
Student’s t test was used.
Awareness of the most fearful side effects of cancer treatment among men and women
| Side effect | Total (rank) | Men (rank) | Women (rank) | Rank difference (men-women) |
|---|---|---|---|---|
| Pain | 1 | 1 | 1 | 0 |
| Fatigue | 5 | 5 | 5 | 0 |
| General weakness | 3 | 3 | 3 | 0 |
| Digestive dysfunction | 4 | 4 | 4 | 0 |
| Sexual dysfunction | 9 | 8 | 11 | –3 |
| Psychological problems | 2 | 2 | 2 | 0 |
| Urological dysfunction | 10 | 9 | 10 | –1 |
| Motor dysfunction | 11 | 11 | 9 | 2 |
| Sensory dysfunction | 7 | 10 | 7 | 3 |
| Appearance change | 6 | 6 | 6 | 0 |
| Lymphedema | 8 | 7 | 8 | –1 |
| Infertility | 12 | 12 | 12 | 0 |
Comparison of fear of side effects of cancer treatment between men and women
| Side effect | Men | Women | p-value[ |
|---|---|---|---|
| Pain | 2.07±1.20 | 2.10±1.14 | 0.703 |
| Fatigue | 0.49±0.90 | 0.57±0.99 | 0.169 |
| General weakness | 0.66±0.93 | 0.82±1.01 | 0.011 |
| Digestive dysfunction | 0.58±0.91 | 0.65±0.95 | 0.259 |
| Sexual dysfunction | 0.23±0.64 | 0.08±0.40 | < 0.001 |
| Psychological problems | 0.83±1.08 | 0.85±1.07 | 0.776 |
| Urological dysfunction | 0.21±0.66 | 0.09±0.39 | 0.001 |
| Motor dysfunction | 0.10±0.44 | 0.09±0.42 | 0.780 |
| Sensory dysfunction | 0.16±0.53 | 0.19±0.62 | 0.500 |
| Appearance change | 0.41±0.82 | 0.44±0.86 | 0.525 |
| Lymphedema | 0.24±0.73 | 0.11±0.45 | 0.001 |
| Infertility | 0.01±0.16 | 0.02±0.17 | 0.842 |
Values are presented as mean±standard deviation.
Student’s t test was used.